Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:2655-2662

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Jong, S. C.
Right arrow Articles by Rauwerda, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Jong, S. C.
Right arrow Articles by Rauwerda, J. A.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:2655-2662.)
© 1997 American Heart Association, Inc.


Articles

High Prevalence of Hyperhomocysteinemia and Asymptomatic Vascular Disease in Siblings of Young Patients With Vascular Disease and Hyperhomocysteinemia

Sylvia C. de Jong; Coen D. A. Stehouwer; Albert J. C. Mackaay; Michiel van den Berg; Ellen J. Bulterijs; Frans C. Visser; Jeroen Bax; ; Jan A. Rauwerda

From the Institute for Cardiovascular Research, Vrije Universiteit, Amsterdam, The Netherlands (S.C. de J., C.D.A.S., A.J.C.M., M. van den B., F.C.V., J.A.R.) and the Departments of Surgery, (S.C. de J., A.J.C.M., M. van den B., E.J.B., J.A.R.), Internal Medicine, (C.D.A.S.), Cardiology, (F.C.V., J.B.), Academisch Ziekenhuis Vrije Universiteit, Amsterdam, The Netherlands

Correspondence to Dr S.C. de Jong, Department of Surgery, Academisch Ziekenhuis Vrije Universiteit, De Boelelaan 1117, PO Box 7057, 1007 MB Amsterdam, The Netherlands.

Abstract Hyperhomocysteinemia (HHC) is associated with an increased risk of atherosclerotic vascular disease and may be inherited. Fasting and postmethionine HHC are independent risk factors that overlap to a limited extent. To study the familial occurrence of HHC, we investigated the prevalence of HHC (both fasting and after methionine) among 450 siblings of 167 consecutive young patients with vascular disease and postmethionine HHC. Furthermore, all subjects with postmethionine HHC (n=125) were invited for noninvasive vascular testing; 101 (80.8%) agreed. Of those with a normal postmethionine plasma level (n=325), we randomly selected 73 subjects for further studies; 53 agreed (72.6%). Thus, a total of 154 siblings underwent ultrasonography of the carotid arteries, measurement of ankle-brachial pressure indices at rest and after a treadmill exercise test, and exercise electrocardiographic stress testing. We observed HHC after methionine, fasting, or both, in 27.8% (95% CI, 23.7 to 31.9), 11.1% (CI, 8.2 to 14.0) and 8.7% (CI, 6.1 to 11.3) of the siblings. Abnormal peripheral, coronary, or carotid artery tests were observed in 35.7% (CI, 28.1 to 43.3), 7.1% (CI, 3.0 to 11.2), and 7.1% (CI, 3.0 to 11.2). Univariate and multivariate analyses revealed weak evidence of a relationship with homocysteine levels.

In conclusion, we found a high prevalence of HHC and asymptomatic vascular disease in siblings of young patients with vascular (mainly peripheral arterial) disease and HHC. Our data raise the possibility that homocysteine does not play a major role in the early, asymptomatic phases of vascular disease, at least among siblings of young patients with vascular disease.


Key Words: hyperhomocysteinemia • vascular testing • vascular disease




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. A.J.M. van Dijk, J. A. Rauwerda, M. Steyn, J. W.R. Twisk, and C. D.A. Stehouwer
Long-Term Homocysteine-Lowering Treatment With Folic Acid Plus Pyridoxine Is Associated With Decreased Blood Pressure but Not With Improved Brachial Artery Endothelium-Dependent Vasodilation or Carotid Artery Stiffness: A 2-Year, Randomized, Placebo-Controlled Trial
Arterioscler. Thromb. Vasc. Biol., December 1, 2001; 21(12): 2072 - 2079.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Lambert, M. van den Berg, M. Steyn, J. A. Rauwerda, A. J.M. Donker, and C. D.A. Stehouwer
Familial hyperhomocysteinaemia and endothelium-dependent vasodilatation and arterial distensibility of large arteries
Cardiovasc Res, June 1, 1999; 42(3): 743 - 751.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. C. de Jong, C. D. A. Stehouwer, M. van den Berg, P. J. Kostense, D. Alders, C. Jakobs, G. Pals, and J. A. Rauwerda
Determinants of Fasting and Post-Methionine Homocysteine Levels in Families Predisposed to Hyperhomocysteinemia and Premature Vascular Disease
Arterioscler. Thromb. Vasc. Biol., May 1, 1999; 19(5): 1316 - 1324.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. D. A. Stehouwer, M. P. Weijenberg, M. van den Berg, C. Jakobs, E. J. M. Feskens, and D. Kromhout
Serum Homocysteine and Risk of Coronary Heart Disease and Cerebrovascular Disease in Elderly Men : A 10-Year Follow-Up
Arterioscler. Thromb. Vasc. Biol., December 1, 1998; 18(12): 1895 - 1901.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. H. Kuller and R. W. Evans
Homocysteine, Vitamins, and Cardiovascular Disease
Circulation, July 21, 1998; 98(3): 196 - 199.
[Full Text] [PDF]